Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 297

1.

Predictors of isoniazid preventive therapy completion among HIV-infected patients receiving differentiated and non-differentiated HIV care in rural Uganda.

Tram KH, Mwangwa F, Chamie G, Atukunda M, Owaraganise A, Ayieko J, Jain V, Clark TD, Kwarisiima D, Petersen ML, Kamya MR, Charlebois ED, Havlir DV, Marquez C; SEARCH collaboration.

AIDS Care. 2019 Jun 10:1-9. doi: 10.1080/09540121.2019.1619661. [Epub ahead of print]

PMID:
31181961
2.

Reduced exposure to piperaquine in young children, compared to adults, in children receiving dihydroartemisinin-piperaquine as malaria chemoprevention.

Whalen ME, Kajubi R, Chamankhah N, Huang L, Orukan F, Wallender E, Kamya MR, Dorsey G, Jagannathan P, Rosenthal PJ, Mwebaza N, Aweeka FT.

Clin Pharmacol Ther. 2019 Jun 7. doi: 10.1002/cpt.1534. [Epub ahead of print]

PMID:
31173649
3.

LLIN Evaluation in Uganda Project (LLINEUP) - Impact of long-lasting insecticidal nets with, and without, piperonyl butoxide on malaria indicators in Uganda: study protocol for a cluster-randomised trial.

Staedke SG, Kamya MR, Dorsey G, Maiteki-Sebuguzi C, Gonahasa S, Yeka A, Lynd A, Opigo J, Hemingway J, Donnelly MJ.

Trials. 2019 Jun 3;20(1):321. doi: 10.1186/s13063-019-3382-8.

4.

Gendered dimensions of population mobility associated with HIV across three epidemics in rural Eastern Africa.

Camlin CS, Akullian A, Neilands TB, Getahun M, Bershteyn A, Ssali S, Geng E, Gandhi M, Cohen CR, Maeri I, Eyul P, Petersen ML, Havlir DV, Kamya MR, Bukusi EA, Charlebois ED.

Health Place. 2019 May;57:339-351. doi: 10.1016/j.healthplace.2019.05.002. Epub 2019 May 29.

5.

Trends of admissions and case fatality rates among medical in-patients at a tertiary hospital in Uganda; A four-year retrospective study.

Kalyesubula R, Mutyaba I, Rabin T, Andia-Biraro I, Alupo P, Kimuli I, Nabirye S, Kagimu M, Mayanja-Kizza H, Rastegar A, Kamya MR.

PLoS One. 2019 May 14;14(5):e0216060. doi: 10.1371/journal.pone.0216060. eCollection 2019.

6.

Malaria Burden through Routine Reporting: Relationship between Incidence and Test Positivity Rates.

Kigozi SP, Kigozi RN, Sserwanga A, Nankabirwa JI, Staedke SG, Kamya MR, Pullan RL.

Am J Trop Med Hyg. 2019 May 6. doi: 10.4269/ajtmh.18-0901. [Epub ahead of print]

PMID:
31074412
7.

Men's Beliefs About the Likelihood of Serodiscordance in Couples with an HIV-Positive Partner: Survey Evidence from Rural Uganda.

Ndyabakira A, Chamie G, Emperador D, Marson K, Kamya MR, Havlir DV, Kwarisiima D, Thirumurthy H.

AIDS Behav. 2019 May 9. doi: 10.1007/s10461-019-02531-7. [Epub ahead of print]

PMID:
31073946
8.

Hypertension control in integrated HIV and chronic disease clinics in Uganda in the SEARCH study.

Kwarisiima D, Atukunda M, Owaraganise A, Chamie G, Clark T, Kabami J, Jain V, Byonanebye D, Mwangwa F, Balzer LB, Charlebois E, Kamya MR, Petersen M, Havlir DV, Brown LB.

BMC Public Health. 2019 May 6;19(1):511. doi: 10.1186/s12889-019-6838-6.

9.

Delayed Antiretroviral Therapy (ART) Initiation among Hospitalized Adults in a Resource-Limited Settings: A Challenge to the Global Target of ART for 90% of HIV-Infected Individuals.

Ingabire PM, Semitala F, Kamya MR, Nakanjako D.

AIDS Res Treat. 2019 Apr 1;2019:1832152. doi: 10.1155/2019/1832152. eCollection 2019.

10.

Systemic inflammation is associated with malaria and preterm birth in women living with HIV on antiretrovirals and co-trimoxazole.

McDonald CR, Weckman AM, Conroy AL, Olwoch P, Natureeba P, Kamya MR, Havlir DV, Dorsey G, Kain KC.

Sci Rep. 2019 May 1;9(1):6758. doi: 10.1038/s41598-019-43191-w.

11.

Distance to clinic is a barrier to PrEP uptake and visit attendance in a community in rural Uganda.

Mayer CM, Owaraganise A, Kabami J, Kwarisiima D, Koss CA, Charlebois ED, Kamya MR, Petersen ML, Havlir DV, Jewell BL.

J Int AIDS Soc. 2019 Apr;22(4):e25276. doi: 10.1002/jia2.25276.

12.

Household and maternal risk factors for malaria in pregnancy in a highly endemic area of Uganda: a prospective cohort study.

Okiring J, Olwoch P, Kakuru A, Okou J, Ochokoru H, Ochieng TA, Kajubi R, Kamya MR, Dorsey G, Tusting LS.

Malar J. 2019 Apr 23;18(1):144. doi: 10.1186/s12936-019-2779-x.

13.

The prevalence of histologic acute chorioamnionitis among HIV infected pregnant women in Uganda and its association with adverse birth outcomes.

Ategeka J, Wasswa R, Olwoch P, Kakuru A, Natureeba P, Muehlenbachs A, Kamya MR, Dorsey G, Rizzuto G.

PLoS One. 2019 Apr 11;14(4):e0215058. doi: 10.1371/journal.pone.0215058. eCollection 2019.

14.

Monthly sulfadoxine-pyrimethamine versus dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in pregnancy: a double-blind, randomised, controlled, superiority trial.

Kajubi R, Ochieng T, Kakuru A, Jagannathan P, Nakalembe M, Ruel T, Opira B, Ochokoru H, Ategeka J, Nayebare P, Clark TD, Havlir DV, Kamya MR, Dorsey G.

Lancet. 2019 Apr 6;393(10179):1428-1439. doi: 10.1016/S0140-6736(18)32224-4. Epub 2019 Mar 22.

PMID:
30910321
15.

Group Mentorship Model to Enhance the Efficiency and Productivity of PhD Research Training in Sub-Saharan Africa.

Manabe YC, Nambooze H, Okello ES, Kamya MR, Katabira ET, Ssinabulya I, Kaddumukasa M, Nabunnya Y, Bollinger RC, Sewankambo NK.

Ann Glob Health. 2018 Apr 30;84(1):170-175. doi: 10.29024/aogh.25.

PMID:
30873808
16.

Persistence of chloroquine resistance alleles in malaria endemic countries: a systematic review of burden and risk factors.

Ocan M, Akena D, Nsobya S, Kamya MR, Senono R, Kinengyere AA, Obuku EA.

Malar J. 2019 Mar 12;18(1):76. doi: 10.1186/s12936-019-2716-z.

17.

LLIN Evaluation in Uganda Project (LLINEUP): a cross-sectional survey of species diversity and insecticide resistance in 48 districts of Uganda.

Lynd A, Gonahasa S, Staedke SG, Oruni A, Maiteki-Sebuguzi C, Dorsey G, Opigo J, Yeka A, Katureebe A, Kyohere M, Hemingway J, Kamya MR, Donnelly MJ.

Parasit Vectors. 2019 Mar 12;12(1):94. doi: 10.1186/s13071-019-3353-7.

18.

K13-propeller gene polymorphisms in Plasmodium falciparum parasite population in malaria affected countries: a systematic review of prevalence and risk factors.

Ocan M, Akena D, Nsobya S, Kamya MR, Senono R, Kinengyere AA, Obuku E.

Malar J. 2019 Mar 7;18(1):60. doi: 10.1186/s12936-019-2701-6.

19.

A Patient-Centered Multicomponent Strategy for Accelerated Linkage to Care Following Community-Wide HIV Testing in Rural Uganda and Kenya.

Ayieko J, Petersen ML, Charlebois ED, Brown LB, Clark TD, Kwarisiima D, Kamya MR, Cohen CR, Bukusi EA, Havlir DV, Van Rie A.

J Acquir Immune Defic Syndr. 2019 Apr 1;80(4):414-422. doi: 10.1097/QAI.0000000000001939.

20.

Prevalence and factors associated with asthma among adolescents and adults in Uganda: a general population based survey.

Kirenga BJ, de Jong C, Katagira W, Kasozi S, Mugenyi L, Boezen M, van der Molen T, Kamya MR.

BMC Public Health. 2019 Feb 22;19(1):227. doi: 10.1186/s12889-019-6562-2.

21.

Factors predictive of successful retention in care among HIV-infected men in a universal test-and-treat setting in Uganda and Kenya: A mixed methods analysis.

Brown LB, Getahun M, Ayieko J, Kwarisiima D, Owaraganise A, Atukunda M, Olilo W, Clark T, Bukusi EA, Cohen CR, Kamya MR, Petersen ML, Charlebois ED, Havlir DV, Camlin CS.

PLoS One. 2019 Jan 23;14(1):e0210126. doi: 10.1371/journal.pone.0210126. eCollection 2019.

22.

A decade of antiretroviral therapy in Uganda: what are the emerging causes of death?

Kiragga AN, Mubiru F, Kambugu AD, Kamya MR, Castelnuovo B.

BMC Infect Dis. 2019 Jan 21;19(1):77. doi: 10.1186/s12879-019-3724-x.

23.

Case Report: Birth Outcome and Neurodevelopment in Placental Malaria Discordant Twins.

Conroy AL, Bangirana P, Muhindo MK, Kakuru A, Jagannathan P, Opoka RO, Liechty EA, Nakalembe M, Kamya MR, Dorsey G, John CC.

Am J Trop Med Hyg. 2019 Mar;100(3):552-555. doi: 10.4269/ajtmh.18-0659.

PMID:
30628574
24.

A patient-centered multi-component strategy for accelerated linkage to care following community-wide HIV testing in rural Uganda and Kenya.

Ayieko J, Petersen ML, Charlebois ED, Brown LB, Clark TD, Kwarisiima D, Kamya MR, Cohen CR, Bukusi EA, Havlir DV, Van Rie A.

J Acquir Immune Defic Syndr. 2018 Dec 20. doi: 10.1097/QAI.0000000000001939. [Epub ahead of print]

PMID:
30585857
25.

Changing Molecular Markers of Antimalarial Drug Sensitivity across Uganda.

Asua V, Vinden J, Conrad MD, Legac J, Kigozi SP, Kamya MR, Dorsey G, Nsobya SL, Rosenthal PJ.

Antimicrob Agents Chemother. 2019 Feb 26;63(3). pii: e01818-18. doi: 10.1128/AAC.01818-18. Print 2019 Mar.

PMID:
30559133
26.

A Novel, 5-Transcript, Whole-blood Gene-expression Signature for Tuberculosis Screening Among People Living With Human Immunodeficiency Virus.

Rajan JV, Semitala FC, Mehta T, Seielstad M, Montalvo L, Andama A, Asege L, Nakaye M, Katende J, Mwebe S, Kamya MR, Yoon C, Cattamanchi A.

Clin Infect Dis. 2019 Jun 18;69(1):77-83. doi: 10.1093/cid/ciy835.

PMID:
30462176
27.

K13-propeller gene polymorphisms in Plasmodium falciparum parasite population: a systematic review protocol of burden and associated factors.

Ocan M, Akena D, Nsobya S, Kamya MR, Senono R, Kinengyere AA, Obuku E.

Syst Rev. 2018 Nov 17;7(1):199. doi: 10.1186/s13643-018-0866-7.

28.

LLIN Evaluation in Uganda Project (LLINEUP): factors associated with ownership and use of long-lasting insecticidal nets in Uganda: a cross-sectional survey of 48 districts.

Gonahasa S, Maiteki-Sebuguzi C, Rugnao S, Dorsey G, Opigo J, Yeka A, Katureebe A, Kyohere M, Lynd A, Hemingway J, Donnelly M, Kamya MR, Staedke SG.

Malar J. 2018 Nov 13;17(1):421. doi: 10.1186/s12936-018-2571-3.

29.

Persistent Parasitemia Despite Dramatic Reduction in Malaria Incidence After 3 Rounds of Indoor Residual Spraying in Tororo, Uganda.

Nankabirwa JI, Briggs J, Rek J, Arinaitwe E, Nayebare P, Katrak S, Staedke SG, Rosenthal PJ, Rodriguez-Barraquer I, Kamya MR, Dorsey G, Greenhouse B.

J Infect Dis. 2019 Mar 15;219(7):1104-1111. doi: 10.1093/infdis/jiy628.

PMID:
30383230
30.

Risky sexual behavior among patients on long-term antiretroviral therapy: a prospective cohort study in urban and rural Uganda.

Okoboi S, Castelnuovo B, Moore DM, Musaazi J, Kambugu A, Birungi J, Kaleebu P, Nanfuka M, Kamya MR, Van Rie A.

AIDS Res Ther. 2018 Oct 19;15(1):15. doi: 10.1186/s12981-018-0203-1.

31.

In utero priming of highly functional effector T cell responses to human malaria.

Odorizzi PM, Jagannathan P, McIntyre TI, Budker R, Prahl M, Auma A, Burt TD, Nankya F, Nalubega M, Sikyomu E, Musinguzi K, Naluwu K, Kakuru A, Dorsey G, Kamya MR, Feeney ME.

Sci Transl Med. 2018 Oct 17;10(463). pii: eaat6176. doi: 10.1126/scitranslmed.aat6176.

32.

The impact of HIV on the prevalence of asthma in Uganda: a general population survey.

Kirenga BJ, Mugenyi L, de Jong C, Lucian Davis J, Katagira W, van der Molen T, Kamya MR, Boezen M.

Respir Res. 2018 Sep 21;19(1):184. doi: 10.1186/s12931-018-0898-5.

33.

"Hurdles on the path to 90-90-90 and beyond": Qualitative analysis of barriers to engagement in HIV care among individuals in rural East Africa in the context of test-and-treat.

Ayieko J, Brown L, Anthierens S, Van Rie A, Getahun M, Charlebois ED, Petersen ML, Clark TD, Kamya MR, Cohen CR, Bukusi EA, Havlir DV, Camlin CS.

PLoS One. 2018 Aug 30;13(8):e0202990. doi: 10.1371/journal.pone.0202990. eCollection 2018.

34.

Costs of streamlined HIV care delivery in rural Ugandan and Kenyan clinics in the SEARCH Studys.

Shade SB, Osmand T, Luo A, Aine R, Assurah E, Mwebaza B, Mwai D, Owaraganise A, Mwangwa F, Ayieko J, Black D, Brown LB, Clark TD, Kwarisiima D, Thirumurthy H, Cohen CR, Bukusi EA, Charlebois ED, Balzer L, Kamya MR, Petersen ML, Havlir DV, Jain V.

AIDS. 2018 Sep 24;32(15):2179-2188. doi: 10.1097/QAD.0000000000001958.

35.

Geographic differences in the prevalence of hypertension in Uganda: Results of a national epidemiological study.

Lunyera J, Kirenga B, Stanifer JW, Kasozi S, van der Molen T, Katagira W, Kamya MR, Kalyesubula R.

PLoS One. 2018 Aug 1;13(8):e0201001. doi: 10.1371/journal.pone.0201001. eCollection 2018.

36.

Prevalence of chloroquine resistance alleles among Plasmodium falciparum parasites in countries affected by malaria disease since change of treatment policy: a systematic review protocol.

Ocan M, Akena D, Nsobya S, Kamya MR, Senono R, Kinengyere AA, Obuku EA.

Syst Rev. 2018 Jul 27;7(1):108. doi: 10.1186/s13643-018-0780-z.

37.

Quantification of anti-parasite and anti-disease immunity to malaria as a function of age and exposure.

Rodriguez-Barraquer I, Arinaitwe E, Jagannathan P, Kamya MR, Rosenthal PJ, Rek J, Dorsey G, Nankabirwa J, Staedke SG, Kilama M, Drakeley C, Ssewanyana I, Smith DL, Greenhouse B.

Elife. 2018 Jul 25;7. pii: e35832. doi: 10.7554/eLife.35832.

38.

Population mobility associated with higher risk sexual behaviour in eastern African communities participating in a Universal Testing and Treatment trial.

Camlin CS, Akullian A, Neilands TB, Getahun M, Eyul P, Maeri I, Ssali S, Geng E, Gandhi M, Cohen CR, Kamya MR, Odeny T, Bukusi EA, Charlebois ED.

J Int AIDS Soc. 2018 Jul;21 Suppl 4:e25115. doi: 10.1002/jia2.25115.

39.

Dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria during pregnancy and risk of malaria in early childhood: A randomized controlled trial.

Jagannathan P, Kakuru A, Okiring J, Muhindo MK, Natureeba P, Nakalembe M, Opira B, Olwoch P, Nankya F, Ssewanyana I, Tetteh K, Drakeley C, Beeson J, Reiling L, Clark TD, Rodriguez-Barraquer I, Greenhouse B, Wallender E, Aweeka F, Prahl M, Charlebois ED, Feeney ME, Havlir DV, Kamya MR, Dorsey G.

PLoS Med. 2018 Jul 17;15(7):e1002606. doi: 10.1371/journal.pmed.1002606. eCollection 2018 Jul.

40.

Effect of a Patient-Centered Phone Call by a Clinical Officer at Time of HIV Testing on Linkage to Care in Rural Kenya.

Ayieko J, Petersen ML, van Rie A, Wafula E, Opudo W, Clark TD, Kamya MR, Balzer LB, Cohen CR, Bukusi EA, Charlebois ED, Havlir DV.

Open Forum Infect Dis. 2018 May 29;5(6):ofy126. doi: 10.1093/ofid/ofy126. eCollection 2018 Jun 1.

41.

Association Between Recent Overnight Travel and Risk of Malaria: A Prospective Cohort Study at 3 Sites in Uganda.

Arinaitwe E, Dorsey G, Nankabirwa JI, Kigozi SP, Katureebe A, Kakande E, Rek J, Rosenthal PJ, Drakeley C, Kamya MR, Staedke SG.

Clin Infect Dis. 2019 Jan 7;68(2):313-320. doi: 10.1093/cid/ciy478.

42.

Rates of asthma exacerbations and mortality and associated factors in Uganda: a 2-year prospective cohort study.

Kirenga BJ, de Jong C, Mugenyi L, Katagira W, Muhofa A, Kamya MR, Boezen HM, van der Molen T.

Thorax. 2018 Oct;73(10):983-985. doi: 10.1136/thoraxjnl-2017-211157. Epub 2018 May 11.

PMID:
29752346
43.

Early Adopters of Human Immunodeficiency Virus Preexposure Prophylaxis in a Population-based Combination Prevention Study in Rural Kenya and Uganda.

Koss CA, Ayieko J, Mwangwa F, Owaraganise A, Kwarisiima D, Balzer LB, Plenty A, Sang N, Kabami J, Ruel TD, Black D, Camlin CS, Cohen CR, Bukusi EA, Clark TD, Charlebois ED, Petersen ML, Kamya MR, Havlir DV; SEARCH Collaboration.

Clin Infect Dis. 2018 Nov 28;67(12):1853-1860. doi: 10.1093/cid/ciy390.

PMID:
29741594
44.

A Human-Centered Approach to CV Care: Infrastructure Development in Uganda.

Longenecker CT, Kalra A, Okello E, Lwabi P, Omagino JO, Kityo C, Kamya MR, Webel AR, Simon DI, Salata RA, Costa MA.

Glob Heart. 2018 Dec;13(4):347-354. doi: 10.1016/j.gheart.2018.02.002. Epub 2018 Apr 21. Review.

45.

Comparative effectiveness of novel nonmonetary incentives to promote HIV testing.

Chamie G, Schaffer EM, Ndyabakira A, Emperador DM, Kwarisiima D, Camlin CS, Havlir DV, Kahn JG, Kamya MR, Thirumurthy H.

AIDS. 2018 Jul 17;32(11):1443-1451. doi: 10.1097/QAD.0000000000001833.

46.

Supporting capacity for research on malaria in Africa.

Greenwood B, Gaye O, Kamya MR, Kibiki G, Mwapasa V, Phiri KS, Tagbor H, Terlouw D, Bates I, Craig A, Magnussen P, Theander TG, Bhasin A, McCullough H, Schellenberg D.

BMJ Glob Health. 2018 Apr 12;3(2):e000723. doi: 10.1136/bmjgh-2018-000723. eCollection 2018.

47.

Assessment of community-level effects of intermittent preventive treatment for malaria in schoolchildren in Jinja, Uganda (START-IPT trial): a cluster-randomised trial.

Staedke SG, Maiteki-Sebuguzi C, Rehman AM, Kigozi SP, Gonahasa S, Okiring J, Lindsay SW, Kamya MR, Chandler CIR, Dorsey G, Drakeley C.

Lancet Glob Health. 2018 Jun;6(6):e668-e679. doi: 10.1016/S2214-109X(18)30126-8. Epub 2018 Apr 13.

48.

Rapid improvements to rural Ugandan housing and their association with malaria from intense to reduced transmission: a cohort study.

Rek JC, Alegana V, Arinaitwe E, Cameron E, Kamya MR, Katureebe A, Lindsay SW, Kilama M, Staedke SG, Todd J, Dorsey G, Tusting LS.

Lancet Planet Health. 2018 Feb;2(2):e83-e94. doi: 10.1016/S2542-5196(18)30010-X. Epub 2018 Feb 9.

49.

The utility of pharmacokinetic studies for the evaluation of exposure-response relationships for standard dose anti-tuberculosis drugs.

Sekaggya-Wiltshire C, Lamorde M, Kiragga AN, Dooley KE, Kamya MR, Kambugu A, Fehr J, Manabe YC, Castelnuovo B.

Tuberculosis (Edinb). 2018 Jan;108:77-82. doi: 10.1016/j.tube.2017.11.004. Epub 2017 Nov 7. Review.

50.

Delayed Sputum Culture Conversion in Tuberculosis-Human Immunodeficiency Virus-Coinfected Patients With Low Isoniazid and Rifampicin Concentrations.

Sekaggya-Wiltshire C, von Braun A, Lamorde M, Ledergerber B, Buzibye A, Henning L, Musaazi J, Gutteck U, Denti P, de Kock M, Jetter A, Byakika-Kibwika P, Eberhard N, Matovu J, Joloba M, Muller D, Manabe YC, Kamya MR, Corti N, Kambugu A, Castelnuovo B, Fehr JS.

Clin Infect Dis. 2018 Aug 16;67(5):708-716. doi: 10.1093/cid/ciy179.

PMID:
29514175

Supplemental Content

Loading ...
Support Center